Jiangsu Kanion PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Jiangsu Kanion PharmaceuticalLtd has a total shareholder equity of CN¥5.5B and total debt of CN¥1.9M, which brings its debt-to-equity ratio to 0.03%. Its total assets and total liabilities are CN¥7.4B and CN¥1.9B respectively. Jiangsu Kanion PharmaceuticalLtd's EBIT is CN¥482.3M making its interest coverage ratio -9.5. It has cash and short-term investments of CN¥2.5B.
Key information
0.03%
Debt to equity ratio
CN¥1.93m
Debt
Interest coverage ratio | -9.5x |
Cash | CN¥2.50b |
Equity | CN¥5.51b |
Total liabilities | CN¥1.87b |
Total assets | CN¥7.38b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600557's short term assets (CN¥4.2B) exceed its short term liabilities (CN¥1.7B).
Long Term Liabilities: 600557's short term assets (CN¥4.2B) exceed its long term liabilities (CN¥156.5M).
Debt to Equity History and Analysis
Debt Level: 600557 has more cash than its total debt.
Reducing Debt: 600557's debt to equity ratio has reduced from 17.4% to 0.03% over the past 5 years.
Debt Coverage: 600557's debt is well covered by operating cash flow (67543.6%).
Interest Coverage: 600557 earns more interest than it pays, so coverage of interest payments is not a concern.